Vaxcyte Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
PCVX Nasdaq 8731 https://vaxcyte.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vaxcyte Inc

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference - Apr 2nd, 2024 8:05 pm
Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances - Mar 27th, 2024 1:02 am
Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares - Mar 20th, 2024 11:01 pm
30 Biggest Biotechnology Companies in the World - Mar 17th, 2024 12:50 pm
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants - Mar 4th, 2024 1:30 pm
Q4 2023 Vaxcyte Inc Earnings Call - Feb 28th, 2024 5:08 pm
Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know - Feb 28th, 2024 5:00 pm
Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript - Feb 28th, 2024 2:57 pm
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Feb 27th, 2024 9:01 pm
The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte - Feb 27th, 2024 2:11 pm
Why Vaxcyte (PCVX) Might Surprise This Earnings Season - Feb 26th, 2024 1:32 pm
5 Stocks to Buy That Are Poised to Beat on Earnings This Week - Feb 26th, 2024 12:38 pm
Insider Sell: Vaxcyte Inc CFO Andrew Guggenhime Disposes of 8,000 Shares - Feb 23rd, 2024 4:28 am
Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 - Feb 15th, 2024 9:05 pm
Director Heath Lukatch Sells 5,000 Shares of Vaxcyte Inc (PCVX) - Feb 3rd, 2024 4:12 am
Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - Feb 2nd, 2024 11:39 pm
Director Heath Lukatch Sells 4,000 Shares of Vaxcyte Inc (PCVX) - Feb 2nd, 2024 4:02 am
Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference - Feb 1st, 2024 9:05 pm
Vaxcyte Announces Pricing of $750 Million Public Offering - Jan 31st, 2024 4:37 am
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants - Jan 30th, 2024 9:01 pm